Literature DB >> 12629127

Zone-dependent expression of estrogen receptors alpha and beta in human benign prostatic hyperplasia.

Toshifumi Tsurusaki1, Daiyu Aoki, Hiroshi Kanetake, Satoshi Inoue, Masami Muramatsu, Yoshitaka Hishikawa, Takehiko Koji.   

Abstract

Estrogen, which acts through estrogen receptors (ERs) alpha and beta, has been implicated in the pathogenesis of benign and malignant human prostatic tumors, i.e. benign prostatic hyperplasia and prostate cancer, thought to originate from different zones of the prostate [the transition zone (TZ) and peripheral zone (PZ), respectively]. Here, we examined the cellular distribution of ERalpha and ERbeta in human normal and hyperplastic prostate tissues, using in situ hybridization and immunohistochemistry. ERalpha expression was restricted to stromal cells of PZ. In contrast, ERbeta was expressed in the stromal cells of PZ as well as TZ. ERbeta-positive epithelial cells were evenly distributed in PZ and TZ of the prostate. Our results suggest that estrogen may play a crucial role in the pathogenesis of benign prostatic hyperplasia through ERbeta.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12629127     DOI: 10.1210/jc.2002-021015

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  20 in total

1.  ICI 182,780-regulated gene expression in DU145 prostate cancer cells is mediated by estrogen receptor-beta/NFkappaB crosstalk.

Authors:  Yuet-Kin Leung; Ying Gao; Kin-Mang Lau; Xiang Zhang; Shuk-Mei Ho
Journal:  Neoplasia       Date:  2006-04       Impact factor: 5.715

Review 2.  The role of estrogens and estrogen receptors in normal prostate growth and disease.

Authors:  Gail S Prins; Kenneth S Korach
Journal:  Steroids       Date:  2007-11-12       Impact factor: 2.668

3.  Correlation between prostate volume and single nucleotide polymorphisms implicated in the steroid pathway.

Authors:  Jean-Nicolas Cornu; Etienne Audet-Walsh; Sarah Drouin; Pierre Bigot; Antoine Valeri; Georges Fournier; Abdel-Rahmène Azzouzi; Morgan Roupret; Luc Cormier; Stephen Chanock; Chantal Guillemette; Olivier Cussenot; Eric Lévesque; Géraldine Cancel-Tassin
Journal:  World J Urol       Date:  2016-06-08       Impact factor: 4.226

Review 4.  Estrogens and prostate cancer: etiology, mediators, prevention, and management.

Authors:  Shuk-Mei Ho; Ming-Tsung Lee; Hung-Ming Lam; Yuet-Kin Leung
Journal:  Endocrinol Metab Clin North Am       Date:  2011-07-07       Impact factor: 4.741

Review 5.  Estrogens in Male Physiology.

Authors:  Paul S Cooke; Manjunatha K Nanjappa; CheMyong Ko; Gail S Prins; Rex A Hess
Journal:  Physiol Rev       Date:  2017-07-01       Impact factor: 37.312

Review 6.  Estrogen and androgen signaling in the pathogenesis of BPH.

Authors:  Clement K M Ho; Fouad K Habib
Journal:  Nat Rev Urol       Date:  2011-01       Impact factor: 14.432

7.  Sex steroid receptor expression and localization in benign prostatic hyperplasia varies with tissue compartment.

Authors:  Tristan M Nicholson; Priyanka D Sehgal; Sally A Drew; Wei Huang; William A Ricke
Journal:  Differentiation       Date:  2013-06-20       Impact factor: 3.880

Review 8.  Oxidative stress in prostate cancer.

Authors:  Lakshmipathi Khandrika; Binod Kumar; Sweaty Koul; Paul Maroni; Hari K Koul
Journal:  Cancer Lett       Date:  2009-01-30       Impact factor: 8.679

9.  Heat-map visualization of gas chromatography-mass spectrometry based quantitative signatures on steroid metabolism.

Authors:  Ju-Yeon Moon; Hyun-Jin Jung; Myeong Hee Moon; Bong Chul Chung; Man Ho Choi
Journal:  J Am Soc Mass Spectrom       Date:  2009-05-05       Impact factor: 3.109

10.  Identification and localization of estrogen receptor alpha- and beta-positive cells in adult male and female mouse intestine at various estrogen levels.

Authors:  Naoko Kawano; Takehiko Koji; Yoshitaka Hishikawa; Kunihiko Murase; Ikuo Murata; Shigeru Kohno
Journal:  Histochem Cell Biol       Date:  2004-05-08       Impact factor: 4.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.